Dehydroepiandrosterone (DHEA) is a hormone produced by the body’s adrenal glands to produce the male and female sex hormones. DHEA levels peak at about age 25, then go down steadily as you get older. By the time people are 70 to 80 years old, their DHEA levels are only 10 to 20% of those in young adults.

Because levels of DHEA decline with age and in direct correlation to age-related diseases, researchers have wondered if DHEA could be considered an anti-aging hormone.

For any adults, low levels of DHEA are really important to recognize because they’re associated with:

  • Metabolic syndrome
  • Osteoporosis
  • Heart disease
  • Memory loss
  • Breast cancer
  • Lupus
  • Adrenal fatigue
  • Erectile dysfunction
  • Depression
  • Inflammatory bowel disease (IBD)
  • Obesity



If you are experiencing any of these symptoms, it simply makes sense to get your hormones tested, including your DHEA.  At FEWL, we use the super-simple and easy-to-use urine hormone test (called the DUTCH test) to identify DHEA levels and to figure out how to correct the levels of this critically important anti-aging hormone.

Choosing a Supplement:

Just as important, we recommend the right lifestyle changes and the right supplements to correct DHEA levels. This is critical  since the quality of DHEA supplements vary widely. Many products tested don’t have the amount of DHEA in them that the label says they do and worse, many not even contain a useable DHEA form.

Most DHEA supplements are produced in laboratories from diosgenin, a plant sterol extracted from Mexican wild yams (Dioscorea villosa). Some extracts from wild yams are marketed as “natural DHEA.” Advertisers claim that these “natural” extracts are converted into DHEA by the body. But this is not true. Your body can’t covert those extracts into DHEA. For this reason, it is best to look for labels that list DHEA rather than diosgenin or wild yam extract.

It is important to choose high quality DHEA supplements. One way to avoid buying a product with contaminated DHEA is to purchase it through a professional health care provider.

DHEA is available in capsules, tablets, chewing gum, sublingual (under the tongue) drops, and topical (on the skin) creams.

FEWL supplies different DHEA supplements to different clients, depending on their personal needs. You need to know what you need and when to use it – doing our dutch hormone test is critical to finding out. We do this because:

  1. Depending on your DUTCH test, you might need the actual hormone, or you might instead need the building-blocks of the hormone.
  2. There is a massive abuse of DHEA by both consumers and by retailers and practitioners who are not properly testing WHAT YOU NEED AND WHY YOU NEED IT: applying the wrong kind of DHEA supplement at the wrong time will cost you money and time but do you no benefit.

Other useful supplements for hormone balance in general and for DHEA include any of those listed in the FEWL Hormone Balance category.


In particular, FEWL’s hormone-clients do well with Stress Buster, Adrenal Support, Thyroid Pro, Methyl Support, Vitamin D and Stops Cravings as their go-to daily supplements.

Precautions: DHEA can react with some medications and with some medical conditions, which your FEWL coach will review with you if you were interested to learn more or if your DHEA levels were tested low and needed a strategy to correct them.

Senior woman applying lotion or anti-aging cream on her face standing in front of the mirror in the modern bathroom. Female mature Asian female examiming her reflection for wrinkles or ageing signs


Metabolic syndrome

Studies show DHEA helps reduce abdominal fat and improve insulin resistance. Other studies suggest that DHEA helps reduce inflammation in the arteries and reduce arterial stiffness.

Heart disease

Studies link low DHEA levels with an increase in heart disease.

Systemic lupus erythematosus (SLE)

Lupus or SLE is an autoimmune disorder. That means that the body’s immune system mistakenly attacks its own tissue. Several studies show that taking DHEA along with other medications helps improve quality of life for people with lupus, though it probably does not change the overall course of their disease.

Several studies have found that some people who take DHEA supplements may be able take less prescription medication. DHEA may also reduce the frequency of flare ups, enhance mental function, and boost bone mass in women with lupus. Many studies use 200 mg per day of DHEA, which can raise levels of testosterone and lower HDL “good” cholesterol. One study found that a lower dose — 20 to 30 mg — might also work. Most of these studies have been small. More studies are needed to determine whether DHEA is safe and effective for people with lupus.

Adrenal insufficiency

DHEA is one of the hormones made by the adrenal glands. With adrenal insufficiency, the adrenal glands do not make enough hormones, including DHEA and cortisol. That happens either because of problems with the pituitary gland or damage to the adrenal glands themselves (also called Addison’s disease).

Several studies suggest that taking DHEA may help improve mood, fatigue, and well being. In one study, women with this condition who took DHEA supplements reported improved sexuality and sense of well being, including fewer feelings of depression and anxiety.


Studies of people with major depression found that DHEA improved symptoms compared to placebo.


Preliminary studies suggest that DHEA may help reduce bone loss in older women. It doesn’t seem to have the same effect in men.


Studies in humans and animals find that DHEA balance by itself is only partially effective for weight loss, while balancing all the weight-related hormones is required for best results (all the hormones tested by the DUTCH test are related to body weight).

Erectile dysfunction

Because DHEA is converted to testosterone, studies of men have sown longer and more sustained erections with proper DHEA balance.

Improved libido in women

Research suggests that DHEA may help improve sex drive in older women (but not younger women).


Because levels of DHEA decline with age and in direct correlation to age-related diseases, researchers have wondered if DHEA could be considered an anti-aging hormone.


People with HIV tend to have low levels of DHEA. And these levels decrease even more as the disease progresses.

Inflammatory bowel disease (IBD)

DHEA levels appear to be low in people with ulcerative colitis and Crohn’s disease. A small study found that DHEA was effective for use in ulcerative colitis and Crohn’s disease.

Other uses

Studies suggest that DHEA supplementation may be beneficial for other health conditions, including infertility, schizophrenia, cocaine withdrawal, anorexia nervosa, and dementia. More research is needed.


Supporting Research

Alhaj HA, Massey AE, McAllister-Williams RH. Effects of DHEA administration on episodic memory, cortisol and mood in healthy young men: a double-blind, placebo-controlled study. Psychopharmacology (Berl). 2006;188(4):541-551.

Andus T, Klebl F, Rogler G, Bregenzer N, Scholmerich J, Straub RH. Patients with refractory Crohn’s disease or ulcerative colitis respond to dehydroepiandrosterone: a pilot study. Aliment Pharmacol Ther. 2003;17(3):409-414.

Arlt W, Callies F, van Vlijmen JC, Koehler I, Reincke M, Bidlingmaier M, et al. Dehydroepiandrosterone replacement in women with adrenal insufficiency. N Engl J Med. 1999;341(14)-1013-1020.

Barad DH, Gleicher N. Increased oocyte production after treatment with dehydroepiandrosterone. Fertil Steril. 2005;84(3):756.

Barnhart KT, Freeman E, Grisso JA. The effect of dehydroepiandrosterone supplementation to symptomatic perimenopausal women on serum endocrine profiles, lipid parameters, and health-related quality of life. J Clin Endocrinol Metab. 1999;84:3896-3902.

Barry NN, McGuire JL, van Vollenhoven RF. Dehydroepiandrosterone in systemic lupus erythematosus: relationship between dosage, serum levels, and clinical response. J Rheumatol. 1998;25(12):2352-2356.

Baulieu EE. Thomas G, Legrain S, et al. Dehydroepiandrosterone (DHEA), DHEA sulfate, and aging: contribution of the DHEAge study to a sociobiomedical issue. Proc Natl Acad Sci USA. 2000;97(8):4279-4284.

Bloch M, Ish-Shalom S, Greenman Y, Klein E, Latzer Y. Dehydroepiandrosterone treatment effects on weight, bone density, bone metabolism and mood in women suffering from anorexia nervosa – a pilot study. Psychiatry Res. 2012; 200(2-3):544-549.

Broeder CE, Quindry MS, Brittingham K, et al. The Andro Project: Physiological and hormonal influences of androstenedione supplementation in men 35 to 65 years old participating in a high-intensity resistance training program. Arch Intern Med. 160:3093-3104.

Corrigan AB. Dehydroepiandrosterone and sport. [Review]. Med J Aust. 1999;171(4):206-208.

de la Torre B, Hedman M, Befrits R. Blood and tissue dehydroepiandrosterone sulphate levels and their relationship to chronic inflammatory bowel disease. Clin Exp Rheumatol. 1998;16:579-582.

Dyner TS, Lang W, Geaga J, et al. An open-label dose-escalation trial of oral dehydroepiandrosterone tolerance and pharmacokinetics in patients with HIV disease. J Acquir Immune Defic Syndr. 1993;6:459-465.

Finckh A, Berner IC, Aubry-Rozier B, So AK. A randomized controlled trial of dehydroepiandrosterone in postmenopausal women with fibromyalgia. J Rheumatol. 2005;32(7):1336-1340.

Flynn MA, Weaver-Osterholtz D, Sharpe-Timms KL, Allen S, Krause G. Dehydroepiandrosterone replacement in aging humans. J Clin Endocrinol Metabol. 199;84(5):1527-1533.

Genezzani AD, Stomati M, Strucchi C, Puccetti S, Luisi S, Genazzani AR. Oral dehydroepiandrosterone supplementation modulates spontaneous and growth hormone-releasing hormone-induced growth hormone and insulin-like growth factor-1 secretion in early and late postmenopausal women. Fertil Steril. 2001;76(2):241-248.

Gomez-Santos C, Hernandez-Morante JJ, Tebar FJ, Granero E, Garaulet M. Differential effect of oral dehydroepiandrosterone-sulfate on metabolic syndrome features in pre- and postmenopausal obese women. Clin Endocrinol (Oxf).  2012; 77(4):548-554.

Gordon C, Grace E, Emans SJ, Goodman E, Crawford MH, Leboff MS. Changes in bone turnover markers and menstrual function after short-term oral DHEA in young women with anorexia nervosa. J Bone Miner Res. 1999;14:136-145.

Grimley Evans J, Malouf R, Huppert F, van Niekerk JK. Dehydroepiandrosterone (DHEA) supplementation for cognitive function in healthy elderly people. Cochrane Database Syst Rev. 2006;(4):CD006221.

Hansen PA, Han DH, Nolte LA. DHEA protects against visceral obesity and muscle insulin resistance in rats fed a high-fat diet. Am J Physiol. 1997;273:R1704-R1708.

Hinson JP, Raven PW. DHEA deficiency syndrome: a new term for old age? [Commentary]. J Endocrinol. 1999;163:1-5.

Klann RC, Holbrook CT, Nyce JW. Chemotherapy of murine colorectal carcinoma with cisplatin and cisplatin plus 3′- deoxy-3′- azidothymidine. Anticancer Res. 1992;12:781-788.

Kohut ML, Thompson JR, Campbell J, et al., Ingestion of a dietary supplement containing dehydroepiandrosterone (DHEA) and androstenedione has minimal effect on immune function in middle-aged men. J Am Coll Nutr. 2003;22(5):363-371.

Kurita H, Maeshima H, Kida S, et al. Serum dehydroepiandrosterone (DHEA) and DHEA-sulfate (S) levels in medicated patients with major depressive disorder compared with controls. J Affect Disord. 2013; 146(2):205-212.

Labrie F. DHEA as physiological replacement therapy at menopause. J Endocrinol Invest. 1998;21:399-401.

Labrie F, Diamond P, Cusan L, Gomez J-L, Belanger A, Candas B. Effect of 12-month dehydroepiandrosterone replacement therapy on bone, vagina, and endometrium in postmenopausal women. J Clin Endocrinol Metab. 1997;82:3498-3505.

Legrain S, Girard L. Pharmacology and therapeutic effects of dehydroepiandrosterone in older subjects. Drugs Aging. 2003;20(13):949-967.

Libe R, Barbetta L, Dall’Asta C, Salvaggio F, Gala C, Beck-Peccoz P, Ambrosi B. Effects of dehydroepiandrosterone (DHEA) supplementation on hormonal, metabolic and behavioral status in patients with hypoadrenalism. J Endocrinol Invest. 2004;27(8):736-741.

Melchior CL, Ritzmann RF. Dehydroepiandrosterone enhances the hypnotic and hypothermic effects of ethanol and pentobarbital. Pharmacol Biochem Behav. 1992;43:223-227.

Meno-Tetang GML, Hon YY, Jusko WJ. Synergistic interaction between dehydroepiandrosterone and prednisolone in the inhibition of rat lymphocyte proliferation. Immunopharmacol Immunotoxicol. 1996;18(3):443-456.

Moffat SD, Zonderman AB, Harman SM, et al. The relationship between longitudinal declines in dehydroepiandrosterone sulfate concentrations and cognitive performance in older men. Arch Intern Med. 2000;160:2193-2198.

Mortola JF, Yen SS. The effects of oral dehydroepiandrosterone on endocrine-metabolic parameters in postmenopausal women. J Clin Endocrinol Metab. 1990;71(3)696-704.

Nair KS, Rizza RA, O’Brien P, et al. DHEA in elderly women and DHEA or testosterone in elderly men. N Engl J Med. 2006;355:1647-1659.

Narkwichean A, Maalouf W, Campbell BK, Jayaprakasan K. Efficacy of dehydroepiandrosterone to improve ovarian response in women with diminished ovarian reserve: a meta-analysis. Reprod Biol Endocrinol. 2013; 11:44.

Nestler JE, Barlascini CO, Clore JN, Blackard WG. Dehydroepiandrosterone reduces serum low density lipoprotein levels and body fat bud does not alter insulin sensitivity in normal men. J Clin Endocrinol Metab. 1988;66(1):57-61.

Nordmark G, Bengtsson C, Larsson A, Karlsson FA, Sturfelt G, Ronnblom L. Effects of dehydroepiandrosterone supplement on health-related quality of life in glucocorticoid treated female patients with systemic lupus erythematosus. Autoimmunity. 2005;38(7):531-540.

Panjari M, Bell RJ, Jane F, Adams J, Morrow C, Davis SR. The safety of 52 weeks of oral DHEA therapy for postmenopausal women. Maturitas. 2009 Apr 30.

Panjari M, Davis SR. DHEA therapy for women: effect on sexual function and wellbeing. Hum Reprod Update. 2007;13(3):239-248.

Percheron G, Hogrel JY, Denot-Ledunois S, et al., Effect of 1-year oral administration of dehydroepiandrosterone to 60- to 80-year-old individuals on muscle function and cross-sectional area: a double-blind placebo-controlled trial. Arch Intern Med. 2003 Mar 24;163(6):720-727.

Piketty C, Jayle D, Leplege A, et al. Double-blind placebo-controlled trial of oral dehydroepiandrosterone in patients with advanced HIV disease. Clin Endocrinol (Oxf). 2001;55(3):325-330.

Poretsky L, Song L, Brillon DJ, Ferrando S, Chiu J, McElhiney M, Ferenczi A, Sison C, Haller I, Rabkin J. Metabolic and hormonal effects of oral DHEA in premenopausal women with HIV infection: a randomized, prospective, placebo-controlled pilot study. Horm Metab Res. 2009 Mar;41(3):244-249.

Rakel: Integrative Medicine, 3rd ed. Philadelphia, PA: Saunders, An Imprint of Elsevier; 2012.

Reiter WJ, Pycha A, Schatzl G, et al. Dehydroepiandrosterone in the treatment of erectile dysfunction: a prospective, double-blind, randomized, placebo-controlled study. Urology. 1999;53(3):590-595.

Sawalha AH, Kovats S. Dehydroepiandrosterone in systemic lupus erythematosus. Curr Rheumatol Rep. 2008 Aug;10(4):286-91.

Schifitto G. Autonomic performance and dehydroepiandrosterone sulfate levels in HIV-1 infected individuals; relationship to TH1 and TH2 cytokine profile. Arch Neurol. 2000;57(7):1027-1032.

Stoll BA. Review: Dietary supplements of deydroepiandrosterone in relation to breast cancer risk. Eur J Clin Nut. 1999;53:771-775.

Tan RS, Pu SJ. The andropause and memory loss: is there a link between androgen decline and dementia in the aging male? Asian J Androl. 2001;3(3):169-174.

Vallee M, Mayo W, Le Moal M. Role of pregnenolone, dehydroepiandrosterone and their sulfate esters on learning and memory in cognitive aging. Brain Res Rev. 2001;37(1-3):301-312.

van Vollenhoven RF. Dehydroepiandrosterone for the treatment of systemic lupus erythematosus. Expert Opin Pharmacother. 2002;3(1):23-31.

van Vollenhoven RF, Morabito LM, Engleman EG, McGuire JL. Treatment of systemic lupus erythematosus with dehydroepiandrosterone: 50 patients treated up to 12 months. J Rheumatol. 1998;25(2):285-289.

Villareal DT, Holloszy JO. Effect of DHEA on abdominal fat and insulin action in elderly women and men: a randomized controlled trial. JAMA. 2004;292(18):2243-2248.

Voznesensky M, Walsh S, Dauser D, Brindisi J, Kenny AM. The association between dehydroepiandosterone and frailty in older men and women. Age Ageing. 2009 Mar 9.

Weghofer A, Kim A, Barad DH, Gleicher N. The impact of androgen metabolism and FMR1 genotypes on pregnancy potential in women with dehydroepiandrosterone (DHEA) supplementation. Hum Reprod. 2012; 27(11):3287-3293.

Weiss EP, Shah K, Fontana L, Lambert CP, Holloszy JO, Villareal DT. Dehydroepiandrosterone replacement therapy in older adults: 1- and 2-y effects on bone. Am J Clin Nutr. 2009 May;89(5):1459-1467.

Weiss EP, Villareal DT, Ehsani AA, Fontana L, Holloszy JO. Dehydroepiandrosterone replacement therapy in older adults improves indices of arterial stiffness. Aging Cell. 2012; 11(5):876-884.

Williams JR. The effects of dehydroepiandrosterone on carcinogenesis, obesity, the immune system, and aging. Lipids. 2000;35(3):325-331.

Wolkowitz OM, Reus VI, Keebler A, Nelson N, Friedland M, Brizendine L, Roberts E. Double-blind treatment of major depression with dehydroepiandrosterone. Am J Psychiatry. 1999;156:646-649.

Yang J, Schwartz A, Henderson EE. Inhibition of 3′ axido-3′ deoxythymidine-resistant HIV-1 infection by dehydroepiandrosterone in vitro. Biochem Biophys Res Commun. 1994;201(3):1424-1432.

Yen SSC, Morales AJ, Khorram O. Replacement of DHEA in aging men and women. Potential remedial effects. Ann NY Acad Sci. 1995;774:128-142.

Facebook Comments